Purpose | AGM Date | Announcement Date |
---|---|---|
AGM | 8 Aug 2025 | 16 Jul 2025 |
Newspaper Publication-AGM Notice Annual Report for the FY 2024-25 (As Per BSE Announcement Dated on: 16/07/2025) Summary of Proceeding of the 40th Annual General Meeting of the Company held on Friday, August 8, 2025 Voting Results and Scrutinizers Report for 40th Annual General Meeting. (As Per BSE Announcement Dated on: 08.08.2025) | ||
AGM | 17 Sep 2024 | 27 Aug 2024 |
AGM 17/09/2024 Notice of 39th Annual General Meeting (AGM) and Annual Report for FY 2023-24: The AGM of the Company will be held on Tuesday, September 17, 2024 at 04:30 P.M (IST) through Video Conferencing/ other Audio Visual Means to transact the businesses as set forth in the Notice of AGM Summary of proceedings of the Thirty-Ninth Annual General Meeting of the Company. (As Per BSE Announcement Dated on 18.09.2024) Voting Results and scrutinizers Report (As per BSE Announcement Dated on 19/09/2024) |
Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.